Prof. Dr. Rasho Rashkov: Rheumatic patients are more protected than COVID-19 … especially those who take hydroxychloroquine

Patients with rheumatic disease are less likely to suffer from coronavirus, especially those taking hydroxychloroquine. That is why their therapy should not be interrupted during the pandemic, says rheumatologist Prof. Rasho Rashkov and clarifies that he and his colleagues have many years of experience in the treatment with hydroxychloroquine, as well as treatment of some of the complications caused by the infection.

The full article is available here in Bulgarian.